2026年全球人工智慧（AI）病理分析系統市場報告

近年來，人工智慧病理分析系統市場發展迅速。預計該市場規模將從2025年的660.6億美元成長至2026年的780.2億美元，複合年成長率達18.1%。推動這一成長的因素包括：慢性病和感染疾病病率上升導致診斷需求增加；全球醫院和實驗室基礎設施的進步；病理工作流程中數位影像診斷技術的日益普及；許多地區熟練病理醫師短缺；以及醫學領域基礎電腦輔助診斷（CAD）工具的發展。

未來幾年，人工智慧病理分析系統的市場規模預計將快速成長。到2030年，預計市場規模將達到1,530.2億美元，複合年成長率（CAGR）為18.3%。預測期內的成長預計將受到以下因素的推動：用於醫學影像分析的人工智慧和深度學習演算法的進步；精準醫療和基於基因組分析的診斷技術的擴展；雲端醫療數據生態系統的日益普及；遠距病理學和遠距離診斷服務的發展；以及醫療保健產業在數位轉型和自動化方面投入的增加。預測期內的關鍵趨勢包括：用於高精度疾病檢測的人工智慧數位病理平台的廣泛應用；用於遠距離診斷的雲端病理資料管理系統的日益普及；深度學習模型在組織病理學影像解讀中的整合不斷推進；診斷檢查室中自動化切片掃描和數位化工作流程解決方案的擴展；以及腫瘤學和疾病篩檢領域對人工智慧輔助臨床決策支援系統日益成長的需求。

癌症發生率的上升預計將推動人工智慧病理分析系統市場的成長。癌症是一種以異常細胞不受控制地增殖為特徵的疾病，這些細胞會侵入並轉移到身體的其他部位。癌症可發生於各種組織和器官，並根據其起源的細胞或組織類型進行分類。罹癌風險老齡化增加而增加，隨著平均壽命的延長，癌症發生率也隨之上升。人工智慧病理分析系統能夠自動分析切片檢查和組織樣本，以檢測、分類和量化癌細胞，從而輔助癌症診斷。這有助於更快、更準確地診斷癌症，並促進癌症的早期發現。例如，根據英國的麥克米倫癌症援助組織的數據，截至2024年8月，英國有超過300萬癌症患者，預計到2025年這一數字將增至350萬，到2030年將增至400萬，到2040年將增至530萬。因此，癌症發生率的上升正在推動人工智慧（AI）病理分析系統市場的成長。

在人工智慧（AI）病理分析系統市場中，領先企業正致力於開發先進的解決方案，例如AI驅動的癌症檢測和診斷支援平台，以應對日益嚴峻的挑戰，包括簡化病理工作流程、提高診斷準確性、加快臨床決策以及緩解醫療系統中病理學家短缺的問題。 AI驅動的癌症檢測和診斷支援平台是一種軟體系統，它利用人工智慧分析醫療數據和影像，幫助醫療專業人員識別潛在的癌症異常並做出更準確的診斷決策。例如，2025年4月，總部位於美國的醫療科技公司Paige.AI Inc.憑藉其AI應用Paige PanCancer Detect獲得了美國食品藥物管理局（FDA）的突破性醫療器材認定。此應用旨在幫助病理學家識別多種組織和器官類型中的癌症區域。該系統利用先進的人工智慧技術，不僅能夠檢測常見的癌症突變，還能檢測罕見的癌症突變，進而提高診斷準確性並縮短病理工作流程時間。透過簡化病例篩檢流程並支持更快速的臨床決策，我們旨在應對全球病理學家日益短缺的問題。此認證凸顯了人工智慧在精準腫瘤學領域日益重要的作用，並進一步鞏固了Paige在開發經監管機構批准的數位病理解決方案方面的地位，從而提高癌症檢測的準確性和患者照護。

目錄

第1章：執行摘要

第2章 市場特徵

• 市場定義和範圍
• 市場區隔
• 主要產品和服務概述
• 全球人工智慧（AI）病理分析系統市場：吸引力評分及分析
• 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

• 供應鏈與生態系概述
• 清單：主要原料、資源和供應商
• 主要經銷商和通路合作夥伴名單
• 主要最終用戶列表

第4章：全球市場趨勢與策略

• 關鍵科技與未來趨勢
  • 人工智慧和自主智慧
  • 生物技術、基因組學和精準醫療
  • 數位化、雲端運算、巨量資料、網路安全
  • 工業4.0和智慧製造
  • 物聯網、智慧基礎設施、互聯生態系統
• 主要趨勢
  • 擴大人工智慧驅動的數位病理平台的應用，以實現高精度疾病檢測。
  • 擴大基於雲端的病理數據管理系統在遠距離診斷的應用
  • 深度學習模型在組織病理影像分析中的應用正在不斷發展。
  • 在診斷檢查室中推廣自動化玻片掃描和數位化工作流程解決方案
  • 腫瘤學和疾病篩檢領域對人工智慧驅動的臨床決策支援系統的需求日益成長。

第5章 終端用戶產業市場分析

• 醫院
• 診斷檢查室
• 研究機構
• 製藥和生物技術公司
• 學術醫療中心和病理網路

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

• 全球人工智慧（AI）病理分析系統市場：PESTEL分析
• 全球人工智慧（AI）病理分析系統市場：規模、對比及成長率分析
• 全球人工智慧（AI）病理分析系統市場表現：規模與成長，2020-2025年
• 全球人工智慧（AI）病理分析系統市場預測：規模與成長，2025-2030年，2035年

第8章：全球市場總規模（TAM）

第9章 市場細分

• 按組件
• 軟體、硬體和服務
• 透過技術
• 機器學習、電腦視覺、自然語言處理
• 最終用戶
• 醫院、診斷檢測實驗室、研究機構、製藥和生物技術公司
• 按類型細分：軟體
• 影像分析軟體、工作流程管理軟體、資料管理軟體、報表建立和視覺化軟體、品管軟體
• 按類型細分：硬體
• 幻燈片掃描器、數位顯微鏡、伺服器和儲存系統、高效能運算系統、成像設備
• 按類型細分：服務
• 實施和整合服務、維護和支援服務、諮詢服務、培訓和教育服務、數據分析和解釋服務

第10章 市場與產業指標：依國家分類

第11章 區域與國別分析

第12章 亞太市場

第13章：中國市場

第14章：印度市場

第15章：日本市場

第16章：澳洲市場

第17章：印尼市場

第18章：韓國市場

第19章 台灣市場

第20章：東南亞市場

第21章 西歐市場

第22章英國市場

第23章：德國市場

第24章：法國市場

第25章：義大利市場

第26章：西班牙市場

第27章 東歐市場

第28章：俄羅斯市場

第29章 北美市場

第30章：美國市場

第31章：加拿大市場

第32章：南美洲市場

第33章：巴西市場

第34章 中東市場

第35章：非洲市場

第36章 市場監理與投資環境

第37章：競爭格局與公司概況

• 人工智慧（AI）病理分析系統市場：競爭格局及市場佔有率（2024年）
• 人工智慧（AI）病理分析系統市場：公司評估矩陣
• 人工智慧（AI）病理分析系統市場：公司概況
  • F. Hoffmann-La Roche Ltd.
  • Danaher Corporation
  • Koninklijke Philips NV
  • Hologic Inc.
  • Tempus AI Inc.

第38章 其他大型企業和創新企業

• Owkin Inc., OptraSCAN Inc., Proscia Inc., Tribun Health, 3DHISTECH Ltd., Visiopharm A/S, Indica Labs Inc., Ibex Medical Analytics Ltd., Mindpeak GmbH, Aiosyn, DeepBio Inc., AIRA Matrix Pvt. Ltd., Aiforia Technologies Plc., Lunit Inc., Google Cloud

第39章 全球市場競爭基準分析與儀錶板

第40章：預計進入市場的新創企業

第41章 重大併購

第42章 具有高市場潛力的國家、細分市場與策略

• 2030年人工智慧（AI）病理分析系統市場：提供新機會的國家
• 2030年人工智慧（AI）病理分析系統市場：蘊藏新機會的細分市場
• 2030年人工智慧（AI）病理分析系統市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手的策略

第43章附錄

Artificial intelligence (AI)-powered pathology analysis system is a technology-driven solution that employs artificial intelligence and machine learning algorithms to examine medical images, histopathology slides, and diagnostic information for accurate and efficient disease identification. Its primary objective is to improve diagnostic precision, shorten turnaround times, reduce human error, and assist pathologists in making informed clinical decisions.

The primary components of artificial intelligence (AI)-powered pathology analysis system include software, hardware, and services. Software refers to AI-driven platforms that evaluate pathology images and clinical data to support disease detection, diagnosis, and workflow optimization. These systems utilize technologies including machine learning, computer vision, and natural language processing and are utilized by end users including hospitals, diagnostic laboratories, research institutes, and pharmaceutical and biotech companies.

Tariffs are influencing the AI-powered pathology analysis system market by increasing the cost of imported advanced imaging hardware, slide scanners, computing infrastructure, and semiconductor components required for high-performance diagnostic systems. This is disrupting global supply chains and slowing deployment in hospitals and diagnostic laboratories, particularly in regions such as Asia-Pacific and Latin America that rely heavily on imported medical technologies. Hardware-intensive segments such as digital microscopes and high-performance computing systems are most affected due to their dependency on specialized components. However, tariffs are also encouraging localized manufacturing of medical devices, regional data infrastructure development, and accelerated innovation in cost-efficient AI software solutions, supporting long-term market resilience.

The artificial intelligence (AI)-powered pathology analysis system market size has grown rapidly in recent years. It will grow from $66.06 billion in 2025 to $78.02 billion in 2026 at a compound annual growth rate (CAGR) of 18.1%. The growth in the historic period can be attributed to rising prevalence of chronic and infectious diseases increasing diagnostic demand, growth in hospital and laboratory infrastructure globally, increasing adoption of digital imaging in pathology workflows, shortage of skilled pathologists in many regions, development of basic computer-assisted diagnostic tools in healthcare.

The artificial intelligence (AI)-powered pathology analysis system market size is expected to see rapid growth in the next few years. It will grow to $153.02 billion in 2030 at a compound annual growth rate (CAGR) of 18.3%. The growth in the forecast period can be attributed to advancement in ai and deep learning algorithms for medical image analysis, expansion of precision medicine and genomics-driven diagnostics, increasing adoption of cloud-based healthcare data ecosystems, growth in telepathology and remote diagnostic services, rising investment in healthcare digital transformation and automation. Major trends in the forecast period include increasing adoption of ai-powered digital pathology platforms for high-accuracy disease detection, growing use of cloud-based pathology data management systems for remote diagnostics, rising integration of deep learning models in histopathology image interpretation, expansion of automated slide scanning and digital workflow solutions in diagnostic laboratories, increasing demand for ai-assisted clinical decision support systems in oncology and disease screening.

The increasing cancer incidence is expected to propel the growth of the artificial intelligence (AI)-powered pathology analysis system market going forward. Cancer refers to a disease characterized by the uncontrolled multiplication of abnormal cells that can invade and spread to other parts of the body, originating in various tissues and organs and classified according to the cell or tissue type from which it develops. Cancer incidence is increasing due to rising life expectancy, as the risk of developing cancer grows with age. Artificial intelligence (AI)-powered pathology analysis systems support cancer diagnosis by automatically analyzing biopsy and tissue samples to detect, classify, and quantify cancerous cells, enabling faster and more accurate diagnosis while supporting early cancer detection. For instance, in August 2024, according to Macmillan Cancer Support, a UK-based organization, more than 3 million people in the UK were living with cancer in 2024, with this figure projected to increase to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Therefore, the increasing cancer incidence is driving the growth of the artificial intelligence (AI)-powered pathology analysis system market.

Key companies operating in the artificial intelligence (AI)-powered pathology analysis system market are focusing on developing advanced solutions, such as AI-driven cancer detection and diagnostic support platforms, to enhance pathology workflow efficiency, improve diagnostic accuracy, accelerate clinical decision-making, and address the growing shortage of pathologists in healthcare systems. AI-driven cancer detection and diagnostic support platforms are software systems that use artificial intelligence to analyze medical data and images, helping healthcare professionals identify potential cancerous abnormalities and make more informed diagnostic decisions. For example, in April 2025, Paige.AI Inc., a US-based healthcare technology company, received U.S. Food and Drug Administration (FDA) Breakthrough Device Designation for its AI application Paige PanCancer Detect, which is designed to assist pathologists in identifying cancerous regions across multiple tissue and organ types. The system uses advanced artificial intelligence to detect both common and rare cancer variants, helping improve diagnostic accuracy and reduce turnaround time in pathology workflows. It aims to address the increasing global shortage of pathologists by streamlining case screening and supporting faster clinical decision-making. This recognition highlights the growing role of AI in precision oncology and strengthens Paige's position in developing regulatory-approved digital pathology solutions for improved cancer detection and patient care.

In May 2026, Grundium Oy, a Finland-based medical technology company, acquired Visiopharm A/S for an undisclosed amount. Through this acquisition, Grundium advanced its strategy of building a broader digital and computational pathology platform by integrating Visiopharm's AI-driven precision pathology software with its advanced imaging technology. The combined capabilities established a comprehensive end-to-end pathology solution for diagnostic laboratories, biopharmaceutical development, and research applications. Visiopharm A/S is a Denmark-based company specializing in AI-powered pathology analysis software and related services.

Major companies operating in the artificial intelligence (AI)-powered pathology analysis system market are F. Hoffmann-La Roche Ltd.; Danaher Corporation; Koninklijke Philips N.V.; Hologic Inc.; Tempus AI Inc.; Owkin Inc.; OptraSCAN Inc.; Proscia Inc.; Tribun Health; 3DHISTECH Ltd.; Visiopharm A/S; Indica Labs Inc.; Ibex Medical Analytics Ltd.; Mindpeak GmbH; Aiosyn; DeepBio Inc.; AIRA Matrix Pvt. Ltd.; Aiforia Technologies Plc.; Lunit Inc.; Google Cloud

North America was the largest region in the artificial intelligence (AI)-powered pathology analysis system market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI)-powered pathology analysis system market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the artificial intelligence (AI)-powered pathology analysis system market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial intelligence (AI)-powered pathology analysis system market consists of revenues earned by entities by providing services such as automated image analysis, digital pathology integration, AI-based diagnostic support, pattern recognition, predictive analytics, and clinical decision support systems. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI)-powered pathology analysis system market also includes sales of whole-slide scanners, fluorescence slide scanners, automated microscopy systems, digital pathology workstations, and medical-grade display monitors. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The artificial intelligence (AI)-powered pathology analysis system market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI)-powered pathology analysis system market statistics, including artificial intelligence (AI)-powered pathology analysis system industry global market size, regional shares, competitors with a artificial intelligence (AI)-powered pathology analysis system market share, detailed artificial intelligence (AI)-powered pathology analysis system market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI)-powered pathology analysis system industry. This artificial intelligence (AI)-powered pathology analysis system market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Artificial Intelligence (AI)-Powered Pathology Analysis System Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses artificial intelligence (ai)-powered pathology analysis system market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence (ai)-powered pathology analysis system ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence (ai)-powered pathology analysis system market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Components: Software; Hardware; Services
• 2) By Technology: Machine Learning; Computer Vision; Natural Language Processing
• 3) By End User: Hospitals; Diagnostic Laboratories; Research Institutes; Pharmaceutical And Biotech Companies
• Subsegments:
• 1) By Software: Image Analysis Software; Workflow Management Software; Data Management Software; Reporting And Visualization Software; Quality Control Software
• 2) By Hardware: Slide Scanners; Digital Microscopes; Servers And Storage Systems; High Performance Computing Systems; Imaging Devices
• 3) By Services: Installation And Integration Services; Maintenance And Support Services; Consulting Services; Training And Education Services; Data Analysis And Interpretation Services
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Danaher Corporation; Koninklijke Philips N.V.; Hologic Inc.; Tempus AI Inc.; Owkin Inc.; OptraSCAN Inc.; Proscia Inc.; Tribun Health; 3DHISTECH Ltd.; Visiopharm A/S; Indica Labs Inc.; Ibex Medical Analytics Ltd.; Mindpeak GmbH; Aiosyn; DeepBio Inc.; AIRA Matrix Pvt. Ltd.; Aiforia Technologies Plc.; Lunit Inc.; Google Cloud
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Artificial Intelligence (AI)-Powered Pathology Analysis System Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Artificial Intelligence (AI)-Powered Pathology Analysis System Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Artificial Intelligence (AI)-Powered Pathology Analysis System Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Artificial Intelligence (AI)-Powered Pathology Analysis System Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Artificial Intelligence & Autonomous Intelligence
  • 4.1.2 Biotechnology, Genomics & Precision Medicine
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Increasing Adoption Of AI Powered Digital Pathology Platforms For High Accuracy Disease Detection
  • 4.2.2 Growing Use Of Cloud Based Pathology Data Management Systems For Remote Diagnostics
  • 4.2.3 Rising Integration Of Deep Learning Models In Histopathology Image Interpretation
  • 4.2.4 Expansion Of Automated Slide Scanning And Digital Workflow Solutions In Diagnostic Laboratories
  • 4.2.5 Increasing Demand Of AI Assisted Clinical Decision Support Systems In Oncology And Disease Screening

5. Artificial Intelligence (AI)-Powered Pathology Analysis System Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Diagnostic Laboratories
• 5.3 Research Institutes
• 5.4 Pharmaceutical And Biotech Companies
• 5.5 Academic Medical Centers And Pathology Networks

6. Artificial Intelligence (AI)-Powered Pathology Analysis System Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Artificial Intelligence (AI)-Powered Pathology Analysis System Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Artificial Intelligence (AI)-Powered Pathology Analysis System PESTEL Analysis (Political, Economical, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Artificial Intelligence (AI)-Powered Pathology Analysis System Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Artificial Intelligence (AI)-Powered Pathology Analysis System Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Artificial Intelligence (AI)-Powered Pathology Analysis System Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Artificial Intelligence (AI)-Powered Pathology Analysis System Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Artificial Intelligence (AI)-Powered Pathology Analysis System Market Segmentation

• 9.1. Global Artificial Intelligence (AI)-Powered Pathology Analysis System Market, Segmentation By Components, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Software, Hardware, Services
• 9.2. Global Artificial Intelligence (AI)-Powered Pathology Analysis System Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Machine Learning, Computer Vision, Natural Language Processing
• 9.3. Global Artificial Intelligence (AI)-Powered Pathology Analysis System Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Diagnostic Laboratories, Research Institutes, Pharmaceutical And Biotech Companies
• 9.4. Global Artificial Intelligence (AI)-Powered Pathology Analysis System Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Image Analysis Software, Workflow Management Software, Data Management Software, Reporting And Visualization Software, Quality Control Software
• 9.5. Global Artificial Intelligence (AI)-Powered Pathology Analysis System Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Slide Scanners, Digital Microscopes, Servers And Storage Systems, High Performance Computing Systems, Imaging Devices
• 9.6. Global Artificial Intelligence (AI)-Powered Pathology Analysis System Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Installation And Integration Services, Maintenance And Support Services, Consulting Services, Training And Education Services, Data Analysis And Interpretation Services

10. Artificial Intelligence (AI)-Powered Pathology Analysis System Market, Industry Metrics By Country

• 10.1. Global Artificial Intelligence (AI)-Powered Pathology Analysis System Market, Average Selling Price By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $
• 10.2. Global Artificial Intelligence (AI)-Powered Pathology Analysis System Market, Average Spending Per Capita (Employed) By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $

11. Artificial Intelligence (AI)-Powered Pathology Analysis System Market Regional And Country Analysis

• 11.1. Global Artificial Intelligence (AI)-Powered Pathology Analysis System Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 11.2. Global Artificial Intelligence (AI)-Powered Pathology Analysis System Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. Asia-Pacific Artificial Intelligence (AI)-Powered Pathology Analysis System Market

• 12.1. Asia-Pacific Artificial Intelligence (AI)-Powered Pathology Analysis System Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. Asia-Pacific Artificial Intelligence (AI)-Powered Pathology Analysis System Market, Segmentation By Components, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. China Artificial Intelligence (AI)-Powered Pathology Analysis System Market

• 13.1. China Artificial Intelligence (AI)-Powered Pathology Analysis System Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 13.2. China Artificial Intelligence (AI)-Powered Pathology Analysis System Market, Segmentation By Components, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. India Artificial Intelligence (AI)-Powered Pathology Analysis System Market

• 14.1. India Artificial Intelligence (AI)-Powered Pathology Analysis System Market, Segmentation By Components, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Japan Artificial Intelligence (AI)-Powered Pathology Analysis System Market

• 15.1. Japan Artificial Intelligence (AI)-Powered Pathology Analysis System Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 15.2. Japan Artificial Intelligence (AI)-Powered Pathology Analysis System Market, Segmentation By Components, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Australia Artificial Intelligence (AI)-Powered Pathology Analysis System Market

• 16.1. Australia Artificial Intelligence (AI)-Powered Pathology Analysis System Market, Segmentation By Components, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Indonesia Artificial Intelligence (AI)-Powered Pathology Analysis System Market

• 17.1. Indonesia Artificial Intelligence (AI)-Powered Pathology Analysis System Market, Segmentation By Components, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. South Korea Artificial Intelligence (AI)-Powered Pathology Analysis System Market

• 18.1. South Korea Artificial Intelligence (AI)-Powered Pathology Analysis System Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. South Korea Artificial Intelligence (AI)-Powered Pathology Analysis System Market, Segmentation By Components, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Taiwan Artificial Intelligence (AI)-Powered Pathology Analysis System Market

• 19.1. Taiwan Artificial Intelligence (AI)-Powered Pathology Analysis System Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. Taiwan Artificial Intelligence (AI)-Powered Pathology Analysis System Market, Segmentation By Components, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. South East Asia Artificial Intelligence (AI)-Powered Pathology Analysis System Market

• 20.1. South East Asia Artificial Intelligence (AI)-Powered Pathology Analysis System Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. South East Asia Artificial Intelligence (AI)-Powered Pathology Analysis System Market, Segmentation By Components, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Western Europe Artificial Intelligence (AI)-Powered Pathology Analysis System Market

• 21.1. Western Europe Artificial Intelligence (AI)-Powered Pathology Analysis System Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 21.2. Western Europe Artificial Intelligence (AI)-Powered Pathology Analysis System Market, Segmentation By Components, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. UK Artificial Intelligence (AI)-Powered Pathology Analysis System Market

• 22.1. UK Artificial Intelligence (AI)-Powered Pathology Analysis System Market, Segmentation By Components, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. Germany Artificial Intelligence (AI)-Powered Pathology Analysis System Market

• 23.1. Germany Artificial Intelligence (AI)-Powered Pathology Analysis System Market, Segmentation By Components, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. France Artificial Intelligence (AI)-Powered Pathology Analysis System Market

• 24.1. France Artificial Intelligence (AI)-Powered Pathology Analysis System Market, Segmentation By Components, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Italy Artificial Intelligence (AI)-Powered Pathology Analysis System Market

• 25.1. Italy Artificial Intelligence (AI)-Powered Pathology Analysis System Market, Segmentation By Components, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Spain Artificial Intelligence (AI)-Powered Pathology Analysis System Market

• 26.1. Spain Artificial Intelligence (AI)-Powered Pathology Analysis System Market, Segmentation By Components, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Eastern Europe Artificial Intelligence (AI)-Powered Pathology Analysis System Market

• 27.1. Eastern Europe Artificial Intelligence (AI)-Powered Pathology Analysis System Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 27.2. Eastern Europe Artificial Intelligence (AI)-Powered Pathology Analysis System Market, Segmentation By Components, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Russia Artificial Intelligence (AI)-Powered Pathology Analysis System Market

• 28.1. Russia Artificial Intelligence (AI)-Powered Pathology Analysis System Market, Segmentation By Components, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. North America Artificial Intelligence (AI)-Powered Pathology Analysis System Market

• 29.1. North America Artificial Intelligence (AI)-Powered Pathology Analysis System Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. North America Artificial Intelligence (AI)-Powered Pathology Analysis System Market, Segmentation By Components, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. USA Artificial Intelligence (AI)-Powered Pathology Analysis System Market

• 30.1. USA Artificial Intelligence (AI)-Powered Pathology Analysis System Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. USA Artificial Intelligence (AI)-Powered Pathology Analysis System Market, Segmentation By Components, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. Canada Artificial Intelligence (AI)-Powered Pathology Analysis System Market

• 31.1. Canada Artificial Intelligence (AI)-Powered Pathology Analysis System Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. Canada Artificial Intelligence (AI)-Powered Pathology Analysis System Market, Segmentation By Components, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. South America Artificial Intelligence (AI)-Powered Pathology Analysis System Market

• 32.1. South America Artificial Intelligence (AI)-Powered Pathology Analysis System Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 32.2. South America Artificial Intelligence (AI)-Powered Pathology Analysis System Market, Segmentation By Components, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Brazil Artificial Intelligence (AI)-Powered Pathology Analysis System Market

• 33.1. Brazil Artificial Intelligence (AI)-Powered Pathology Analysis System Market, Segmentation By Components, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Middle East Artificial Intelligence (AI)-Powered Pathology Analysis System Market

• 34.1. Middle East Artificial Intelligence (AI)-Powered Pathology Analysis System Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Middle East Artificial Intelligence (AI)-Powered Pathology Analysis System Market, Segmentation By Components, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Africa Artificial Intelligence (AI)-Powered Pathology Analysis System Market

• 35.1. Africa Artificial Intelligence (AI)-Powered Pathology Analysis System Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 35.2. Africa Artificial Intelligence (AI)-Powered Pathology Analysis System Market, Segmentation By Components, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

36. Artificial Intelligence (AI)-Powered Pathology Analysis System Market Regulatory and Investment Landscape

37. Artificial Intelligence (AI)-Powered Pathology Analysis System Market Competitive Landscape And Company Profiles

• 37.1. Artificial Intelligence (AI)-Powered Pathology Analysis System Market Competitive Landscape And Market Share 2024
  • 37.1.1. Top 10 Companies (Ranked by revenue/share)
• 37.2. Artificial Intelligence (AI)-Powered Pathology Analysis System Market - Company Scoring Matrix
  • 37.2.1. Market Revenues
  • 37.2.2. Product Innovation Score
  • 37.2.3. Brand Recognition
• 37.3. Artificial Intelligence (AI)-Powered Pathology Analysis System Market Company Profiles
  • 37.3.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 37.3.2. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 37.3.3. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
  • 37.3.4. Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 37.3.5. Tempus AI Inc. Overview, Products and Services, Strategy and Financial Analysis

38. Artificial Intelligence (AI)-Powered Pathology Analysis System Market Other Major And Innovative Companies

• Owkin Inc., OptraSCAN Inc., Proscia Inc., Tribun Health, 3DHISTECH Ltd., Visiopharm A/S, Indica Labs Inc., Ibex Medical Analytics Ltd., Mindpeak GmbH, Aiosyn, DeepBio Inc., AIRA Matrix Pvt. Ltd., Aiforia Technologies Plc., Lunit Inc., Google Cloud

39. Global Artificial Intelligence (AI)-Powered Pathology Analysis System Market Competitive Benchmarking And Dashboard

40. Upcoming Startups in the Market

41. Key Mergers And Acquisitions In The Artificial Intelligence (AI)-Powered Pathology Analysis System Market

42. Artificial Intelligence (AI)-Powered Pathology Analysis System Market High Potential Countries, Segments and Strategies

• 42.1. Artificial Intelligence (AI)-Powered Pathology Analysis System Market In 2030 - Countries Offering Most New Opportunities
• 42.2. Artificial Intelligence (AI)-Powered Pathology Analysis System Market In 2030 - Segments Offering Most New Opportunities
• 42.3. Artificial Intelligence (AI)-Powered Pathology Analysis System Market In 2030 - Growth Strategies
  • 42.3.1. Market Trend Based Strategies
  • 42.3.2. Competitor Strategies

43. Appendix

• 43.1. Abbreviations
• 43.2. Currencies
• 43.3. Historic And Forecast Inflation Rates
• 43.4. Research Inquiries
• 43.5. The Business Research Company
• 43.6. Copyright And Disclaimer